FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Wyeth's Bob Essner - CEO pay

Tools

Bob Essner - Wyeth Bob Essner, former Wyeth CEO

Total Compensation: $24.1M

2007 Revenue: $22.4B
2006 Revenue: $20.35B
Change: 10%

Details: Bob Essner's (pictured) 2007 compensation fell to $24.1 million from more than $32 million in 2006, which included $1.7 million in base pay, $10.1 million in stock awards, $4.7 million in options and a $3.2 million bonus. Essner also spent $15,000 on personal use of a company car and driver and $95,000 on air travel. Wyeth's new CEO Bernard Poussot (photo), saw his package decline to $12.7 million from $14.4 million. Poussot took over for outgoing CEO Essner January 1, 2008.

Wyeth News:
Wyeth names Poussot CEO
Wyeth to slash another 1,200 jobs
1,200 Wyeth reps out of work
Wyeth, Pfizer chiefs see pay decline

Bookmark and Share
Get Your FREE FiercePharma Email Newsletter:
Comments (1) | Post a comment
More stories about Wyeth   Pharma CEO pay   Bob Essner   Bernard Poussot  

Comments

As a "Project Impact" ex-exployee I would think that the executives would forego their bonuses ( all or part) to help save the thousands of jobs that have been "impacted". Is it asking too much for executives to live within their means like the rest of us that struggle daily during these troubled times.

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.